VPS29 Is Not an Active Metallo-Phosphatase but Is a Rigid Scaffold Required for Retromer Interaction with Accessory Proteins by Swarbrick, James D. et al.
VPS29 Is Not an Active Metallo-Phosphatase but Is a
Rigid Scaffold Required for Retromer Interaction with
Accessory Proteins
James D. Swarbrick
1, Daniel J. Shaw
2, Sandeep Chhabra
1, Rajesh Ghai
2, Eugene Valkov
3¤, Suzanne J.
Norwood
2, Matthew N. J. Seaman
4, Brett M. Collins
2*
1Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 2Institute for Molecular Bioscience, The University of Queensland, St. Lucia,
Queensland, Australia, 3School of Chemistry and Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia, 4Department of Clinical
Biochemistry, Cambridge Institute for Medical Research, Cambridge University, Cambridge, United Kingdom
Abstract
VPS29 is a key component of the cargo-binding core complex of retromer, a protein assembly with diverse roles in transport
of receptors within the endosomal system. VPS29 has a fold related to metal-binding phosphatases and mediates
interactions between retromer and other regulatory proteins. In this study we examine the functional interactions of
mammalian VPS29, using X-ray crystallography and NMR spectroscopy. We find that although VPS29 can coordinate metal
ions Mn
2+ and Zn
2+ in both the putative active site and at other locations, the affinity for metals is low, and lack of activity in
phosphatase assays using a putative peptide substrate support the conclusion that VPS29 is not a functional
metalloenzyme. There is evidence that structural elements of VPS29 critical for binding the retromer subunit VPS35 may
undergo both metal-dependent and independent conformational changes regulating complex formation, however studies
using ITC and NMR residual dipolar coupling (RDC) measurements show that this is not the case. Finally, NMR chemical shift
mapping indicates that VPS29 is able to associate with SNX1 via a conserved hydrophobic surface, but with a low affinity
that suggests additional interactions will be required to stabilise the complex in vivo. Our conclusion is that VPS29 is a metal
ion-independent, rigid scaffolding domain, which is essential but not sufficient for incorporation of retromer into functional
endosomal transport assemblies.
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Introduction
Retromer is a protein complex peripherally associated with
endosomal organelles, and controls trafficking of a number of
critical cargo molecules within tubulovesicular carriers to the trans
Golgi network (TGN) [1,2,3,4]. Biochemical and genetic studies in
yeast and higher eukaryotes have identified two distinct retromer
sub-complexes; a core trimer composed of VPS35-VPS29-VPS26
(VPS: vacuolar protein sorting) and an associated homo or hetero-
dimer of sorting nexin (SNX) proteins, containing combinations of
SNX1, SNX2, SNX5 and SNX6. The current model postulates
that the core complex is a cargo loading assembly that binds to the
cytoplasmic tails of trafficking receptors such as the cation
independent mannose-6-phosphate receptor (CI-MPR), Wntless,
sortilin and DMT1 via the large VPS35 subunit [5,6,7,8,
9,10,11,12,13,14,15]. The SNX proteins drive the membrane
remodelling required to form the tubulovesicular transport
structures [16,17,18,19], and along with the small GTPase Rab7
may regulate recruitment of retromer to endosomal membranes
through binding to phosphatidylinositol-3-phosphate (PtdIns(3)P)
[18,19,20,21].
The exact roles of the individual subunits of the core retromer
complex remain unclear. The function of the large VPS35 subunit
is perhaps the best defined, as it forms the central scaffold for
assembly with VPS29 and VPS26 [22,23,24,25], it binds directly
to transmembrane cargo molecules [5,7,12], and also associates
with SNX proteins [19,23,26]. It can therefore be thought of as
the primary hub for the spatiotemporal assembly of functional
transport intermediates. The roles of VPS29 and VPS26 are not as
well understood. Each of these proteins is required for the stability
of the core trimer in vivo [22,24,27,28,29], and based on structural
similarity to arrestin molecules it has been suggested that VPS26
may play an ancillary role in recruiting cargo molecules or
accessory proteins [22,29], although there is currently no
experimental evidence for this.
VPS29 is the smallest subunit of retromer and its structure
reveals a striking similarity to Ser/Thr phosphatase enzymes
[24,27,30]. This discovery led to the hypothesis that with VPS35
and VPS26, VPS29 may be the catalytic subunit of a trimeric
phosphatase (core retromer), with some similarity to the PP2A
holoenzyme [2]. Support for this came from the observation that
VPS29 displayed weak phosphatase activity against phosphorylat-
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could find no enzymatic function [24,27]. Further evidence against
the potential phosphatase activity of retromer came from the
crystal structure of VPS29 bound to a fragment of VPS35 [24].
This revealed that the putative active site of VPS29 is buried
within the interface of the two molecules, precluding access to
potential phosphorylated substrates. The ability of VPS29 to
function as a protein phosphatase therefore remains in question.
There are several notable features about the putative VPS29
active site and overlapping VPS35 binding interface. Firstly the
central Asp side-chain, which bridges the two essential divalent
cations in all other phosphatase enzymes, is altered to an Asn in
VPS29 (Asn39). While it was found that Mn
2+ could bind within
this putative active site when soaked into crystals in high molar
excess, this binding resulted in a significant rearrangement in the
local structure, in particular affecting the orientation of Phe63
[27]. The Phe63 side-chain forms an intimate contact with VPS35
in the co-complex structure [24] and our modelling indicates that
steric clashes could potentially inhibit binding to VPS35 if metal
ions are present. Thus there are several possibilities regarding the
role of metal binding by VPS29. It could be critical to phosphatase
activity of VPS29, an activity that will either require other co-
factors or conformational changes in the retromer complex, it may
help to stabilise the VPS29 structure, it may regulate molecular
interactions with VPS35, or it may play no functional role.
A second interesting observation is that the adjacent loop-helix
region of VPS29 encompassing helix a3 is in a dramatically
different orientation when the mouse crystal structure is compared
either with apo or VPS35-bound human VPS29 despite no
significant sequence differences [2,24,27,30]. This raises the
question as to whether this region may be able to adopt multiple
conformations in solution before becoming ordered upon VPS35
association.
It was also shown that a hydrophobic surface on yeast Vps29p
remote from the Vps35p-binding interface and putative active
site is critical for association of t h er e t r o m e rc o r ec o m p l e xw i t h
the yeast SNX paralogues Vps5p-Vps17p, demonstrating a role
for Vps29p in yeast retromer assembly [27]. Recently mamma-
lian VPS29 was shown to be critical for interaction of the
retromer complex with the Rab GTPase activating protein
(GAP) TBC1D5, via the same conserved surface as demonstrat-
ed for the yeast Vps29p-Vps5p/Vps17p interaction [32]. As yet,
direct binding of these proteins to VPS29 remain to be
demonstrated.
In this study we use X-ray crystallography and NMR spec-
troscopy to examine the conformational dynamics and biomolec-
ular interactions of VPS29. Specifically we address three related
questions regarding the activity of VPS29 within retromer; (i) does
VPS29 bind metals, what is their affinity for the protein, and do
they have a functional importance, (ii) does VPS29 undergo
conformational changes when incorporated into the retromer
complex, and (iii) how does VPS29 function in coupling retromer
to regulatory proteins such as SNX1 and TBC1D5? Our
conclusion is that despite retaining vestigial metal-binding capacity
VPS29 is in fact a metal-independent scaffolding protein, that does
not undergo large scale conformational changes on retromer
association and displays specific but weak binding to SNX1 in
solution. We propose this interaction will aid in coupling the
proteins during the formation of dynamic protein networks
required for endosomal trafficking, but on its own does not lead
to stable complex formation. Our study thus lends evidence to the
theory that VPS29 has evolved from a precursor phosphatase
enzyme as a regulator of protein-protein interactions but is no
longer an active metalloenzyme.
Results
Experimental approach and NMR assignment of VPS29
The overall rationale of this study is outlined in Fig. 1. VPS29
has structural similarity to PPP Ser/Thr phosphatase enzymes and
has a putative active site that has the potential to bind metal ions
[27,30]. VPS29 binds VPS35 with high affinity (Kd,250 nM), and
the interface incorporates the metal-binding pocket, the a3 helix
and the Phe63 side-chain [24,25,27]. The a3 helix is known to
adopt different conformations in previous crystal structures
[24,27,30], and Phe63 is known to adopt different conformations
upon metal binding to VPS29 [27]. A conserved hydrophobic
surface that includes the Leu152 side-chain lies opposite to the
VPS35 interface. This is known to be required for binding to
TBC1D5 in mammalian cells [32], and to the SNX complex in
yeast cells [27]. Whether mammalian SNX homo and heterodi-
mers use the same binding surface is unknown. From these
previous studies, there are at least three possible, and not mutually
exclusive, functions for the VPS29 protein. Firstly, it could be a
metal-dependent phosphatase enzyme, secondly, it could be a
scaffolding protein that utilises metal-binding in either a positive or
negative regulatory capacity, or lastly, it may act as a metal-
independent scaffold for assembly of retromer and functional
endosomal trafficking complexes.
In this study we use NMR spectroscopy and X-ray crystallog-
raphy to examine the functional interactions of VPS29, their
affinities, and potential conformational changes in VPS29 upon
Figure 1. Interactions of VPS29 examined in this study. VPS29
has structural similarity to phosphatase enzymes and has the potential
to bind two divalent cations [27]. VPS29 binds VPS35 with an interface
that incorporates the metal-binding pocket, the a3 helix and the Phe63
side-chain [24]. The a3 helix is known to adopt different conformations
in previous crystal structures [24,27,30], and Phe63 is known to adopt
different conformations upon metal binding to VPS29 [27]. A conserved
hydrophobic surface lies opposite to the VPS35 interface, and is known
to be required for binding to TBC1D5 in mammalian cells [32], and to
the heterodimeric SNX complex in yeast [27]. Critically mutation of
Leu152 to Glu is known to abolish these interactions. Note, the SNX
proteins are also thought to form contacts directly with VPS35 [20,23].
doi:10.1371/journal.pone.0020420.g001
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possibilities. As a prerequisite for ligand binding and structural
experiments we performed
15N and
13C triple resonance
experiments to assign the backbone
1H,
15N and
13C resonances
of the mouse VPS29 protein (Fig. 2). VPS29 displays excellent
NMR spectral properties, and we have been able to obtain 97% of
the backbone assignments for the protein. Amide assignments are
missing for Asn16, Ala20, Trp93, Gly94, Glu125 and Ile130. All
backbone NOEs are consistent with the secondary structure
observed in the X-ray structures of VPS29 (data not shown).
Binding of VPS29 to Zn
2+ measured by NMR
spectroscopy
We first revisited the binding of VPS29 to divalent metal ions to
determine the affinity of the protein for these potential ligands.
PPP phosphatases have a requirement for two divalent metal
cations, typically transition metals Mn
2+,Z n
2+,F e
2+ or Ni
2+, but
not Ca
2+ or Mg
2+. We previously showed that VPS29 can bind to
Mn
2+, coordinating two metal ions using conserved Asp, Asn and
His side chains in an almost identical arrangement to that seen in
PPP phosphatase enzyme active sites [27]. To examine the affinity
of metals with the VPS29 protein we employed NMR titration
experiments. Binding of Mn
2+ was not tested, as strong
paramagnetic effects are expected to complicate data interpreta-
tion. Instead, binding of Zn
2+ was followed by examining changes
in the [
1H,
15N]-HSQC spectra of VPS29 upon addition of
increasing concentrations of ZnCl2. These experiments indicated
significant binding of the cation as assessed by the observation of
widespread chemical shift perturbations (Fig. 3A) within either
slow exchange or slow-intermediate exchange NMR time scales.
Saturation occurred at approximately 500 mMZ n
2+ (,5-fold
molar excess).
Figure 2. NMR assignement of VPS29. VPS29 [
1H,
15N]-HSQC spectrum. Assigned peaks are labelled by residue number.
doi:10.1371/journal.pone.0020420.g002
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2+ in solution as determined by NMR spectroscopy. (A) A number of residues in the [
1H,
15N]-HSQC spectra of
VPS29 show specific perturbations on addition of Zn
2+. Spectra are shown of VPS29 in the apo state (black) or in the presence of 200 mM ZnCl2 (red).
Resonances showing significant chemical shift changes are indicated. (B)Z n
2+ binds to VPS29 in solution within the same major pocket identified by
X-ray crystallography. Residues showing significant chemical shift upon Zn titration are highlighted on the structure in red (Dd greater than 2 SD).
Each monomer from the asymmetric unit of the Zn
2+-bound mouse VPS29 crystal structure has been mapped, with crystallographically identified
Zn
2+ ions indicated in blue (see Fig. 3 for details). Note however, that VPS29 is monomeric in solution, not dimeric. No significant evidence is seen for
binding to the low occupancy Zn
2+ site coordinated by Asp55, His57 and His33 (dashed circle). (C) Titration of VPS29 with Zn
2+ can be followed by
observing the change in intensity for the Gly133 NH resonance in bound and unbound states. (D) Plot of the bound and unbound intensity ratio for
the Gly133 NH resonance as a function of Zn
2+ concentration. The blue line shows the fit to the Hill equation. The estimated affinity is low with an
overall Kd.250 mM. (E) Binding of VPS29 to either Mn
2+ or Zn
2+ cannot be measured by ITC, confirming the low affinity of interaction. A weak
endothermic signal is observed upon metal titration at 25uC but the binding affinity cannot be estimated. Top panels show raw data and bottom
panels show integrated normalised data. No significant binding signals were observed under these conditions (0.04 mM protein, 2.5 mM metals,
25uC). Other metals including Mg
2+,C a
2+ and Ni
2+, and temperature regimes from 10–37uC produced similar negative results. (F)M n
2+ and Zn
2+ bind
to EDTA exothermically and with high affinity under identical conditions by ITC (0.2 mM EDTA, 2.5 mM metals, 25uC). The binding affinity is too high
to be determined at the concentrations used.
doi:10.1371/journal.pone.0020420.g003
Molecular Interactions of VPS29
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e20420We assessed binding of Zn
2+ to VPS29 by monitoring the
intensity change of the free NH resonances, and those residues
showing the greatest intensity change were mapped onto the
VPS29 structure (Fig. 3B). The greatest alteration in the chemical
environment corresponds to residues within the putative active site
as identified from previous crystallographic experiments [27]. As
discussed below there is crystallographic evidence for an additional
Zn
2+ binding site distal to the putative active site, however we do
not find significant evidence of binding to this location by NMR
experiments. As some protein precipitation occurred during the
titration it was not generally possible to assign the resonances from
the Zn
2+-bound protein owing to sample instability. Nevertheless,
the Gly133 HN resonance is well resolved and the assignment of
the cation-bound form can be reliably inferred (Fig. 3C).
Furthermore, as the distance to the metal-binding pocket is
,9A ˚, it is expected to be a reliable Zn
2+ binding reporter for the
active site of VPS29.
The affinity of metal binding was examined by plotting the
intensity of the bound peak divided by the sum of the intensities of
the bound and free peak for Gly133 against the molar ratio of zinc
to protein. We observed a sigmoidal shaped binding curve, which
is characteristic of cooperativity (Fig. 3D). This is not unexpected
given that at least two cations are separated by only 3.5 A ˚ within
the putative active site (see below). Fitting the NMR binding data
to the Hill equation suggests positive cooperativity (nH=1.95) and
an overall affinity (Kd).250 mM. No attempt to fit a multi-site,
cooperative model to the NMR data was undertaken given the
ambiguity in the number of metals in the binding site. This weak
Figure 4. Crystal structures of VPS29 bound to Mn
2+ and Zn
2+. Crystal structure of VPS29 determined by X-ray crystallography bound to
either Mn
2+ (A)o rZ n
2+ (B). Top panels show overall protein structures as ribbon diagrams with anomalous difference maps contoured at 3s shown
in red. Each monomer from the asymmetric unit is indicated in green and blue. Mn
2+ ions are shown as magenta spheres, and Zn
2+ ions are shown as
salmon spheres. Middle panels (i) show zoomed in regions of the putative active site residues and bound metal ions. Bottom panels (ii) show
enlarged regions for minor low occupancy sites distal to the major binding pocket.
doi:10.1371/journal.pone.0020420.g004
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calorimetry (ITC) experiments performed with VPS29 and a range
of divalent cations. We were unable to detect significant
association by ITC, indicating either no binding or affinities
below Kd 200–300 mM( Fig. 3E). Binding to EDTA under
identical conditions (Fig. 3F), and to a structurally related PPP
phosphatase GpdQ [33] was readily measured (not shown),
indicating that the inability to detect binding to VPS29 by ITC
likely reflects a true low affinity association.
Crystal structures of VPS29 bound to different divalent
metals
To examine the exact mechanism of VPS29 binding to Zn
2+ we
soaked protein crystals in a solution of ZnSO4 and determined its
structure by X-ray crystallography (Fig. 4; Table 1). Under the
same conditions, crystals could be placed in solutions containing
MnSO4 at up to 100 mM concentration for several hours without
noticeable effects on the crystal quality, however crystals cracked
and degraded using as little as 5–10 mM ZnSO4 in minutes, thus
limiting the resolution of the data we could collect. We obtained a
3.2 A ˚ dataset of VPS29 crystals soaked in 2 mM ZnSO4 for
15 min, and importantly data was collected at the peak
wavelength for Zn
2+ to permit the exploitation of the anomalous
signal in the identification of the metals in their cognate binding
sites. A dataset was also collected for Mn
2+-bound VPS29 at the
same wavelength, where the expected anomalous signal is lower
but still significant. Anomalous difference Fourier maps were
computed using the Bijvoet differences collected at the Zn
2+ peak
wavelength and utilising the protein phases (Fig. 4). In the case of
Mn
2+ soaks, clear density is seen for two bound ions per protein
chain, in an identical coordination to that observed previously
[27]. The anomalous difference Fourier map shows clear density
beyond 4s over the background at the corresponding metal ion
positions in both protein molecules of the asymmetric unit, and the
f0/f9 values of 4 and 2 respectively at this wavelength are consistent
with the sizes of the anomalous density peaks. In addition clear
difference and anomalous difference density was observed for a
bound ion coordinated by Glu123, Asp126 and the main-chain
carbonyl of Lys180 in both chains, although density suggests this
ion is at lower occupancy than the two found in the putative metal-
binding pocket.
The coordination of Zn
2+ within the metal-binding pocket is
essentially identical to Mn
2+, confirming that the ability to bind
metals within this pocket is a general feature of the protein. A pair
of Zn
2+ cations are coordinated by the His and Asp side chains of
the central pocket, and bridged by the conserved Asn39 side chain.
Intriguingly, we also observe an additional bound Zn
2+ ion in one
of the two VPS29 monomers (chain A) in the asymmetric unit.
This Zn
2+ ion is coordinated by His10 and Cys41, in very close
proximity to the active site. The lack of a similar bound Zn
2+ ion
in chain B is likely due to an inhibitory crystal contact in this
region. Evidence for a more weakly occupied Zn
2+ ion is also
found at a distal site coordinated by Asp55, His57 and His33 of
each chain. This latter, apparently lower affinity site was not
detected in our NMR titration experiments (see above).
VPS29 and retromer do not have phosphatase activity
against CI-MPR
Our NMR and crystallography experiments confirm that
VPS29 can associate with different divalent metal cations, but
the very low affinity of these metals calls into question the
functional importance of their binding. As PPP phosphatase
enzymes have an absolute requirement for divalent metal
cations for activity, the key question is whether VPS29 is able
to function as a metallophosphatase. As outlined above we have
not detected activity using small molecule substrates [27], but it
has been reported that VPS29 has activity against a phosphor-
ylated peptide derived from the cargo protein CI-MPR, and this
can be enhanced by the presence of other retromer subunits
[ 3 1 ] .H o w e v e r ,l i k eH i e r r oa n dc o l l e a g u e s[ 2 4 ] ,w h e nw e
perform similar experiments with purified proteins we do not
observe any phosphatase activity towards the phosphorylated
CI-MPR peptide (Fig. 5A, 5B). Data is shown only for
experiments incorporating Zn
2+ and Mn
2+. Other ions, different
pH and higher protein concentrations yield similar results. Our
data, and that of Hierro and colleagues [24], strongly argues
therefore that VPS29 is not a metal-dependent phosphatase
enzyme.
VPS29 binding to VPS35 is not affected by metal ions
Apart from promoting enzymatic activity, another potential role
for metal-binding by VPS29 may be to regulate molecular
interactions via conformational changes in the protein. Crystal
structures of VPS29 bound to Zn
2+ or Mn
2+ presented here and
previously [27] show that the presence of metals within the
conserved pocket causes a small but marked rearrangement of
residues, resulting in particular in a significant shift of the Phe63
side chain orientiation. Within the VPS29-VPS35 sub-assembly of
Table 1. Summary of crystallographic structure
determination statistics
a.
VPS29 (Mn
2+) VPS29 (Zn
2+)
Data collection
Wavelength (A ˚) 1.2398 1.2398
Space group P21 P21
Cell dimensions
a, b, c (A ˚) 42.4, 69.1, 69.0 51.2, 68.6, 62.5
a, b, c (u) 90, 105.4, 90 90, 105.7, 90
Resolution (A ˚) 19.61-2.40 (2.53-2.40) 19.77-3.20 (3.37-3.20)
Rmerge 0.071 (0.442) 0.106 (0.475)
Rmeas 0.092 (0.543) 0.134 (0.602)
I/sI 12.8 (4.0) 10.2 (3.5)
Completeness (%) 99.7 (100) 99.5 (100)
Redundancy 4.5 (4.6) 5.1 (5.2)
Wilson plot B (A ˚) 40.8 89.3
Refinement
Resolution (A ˚) 19.17-2.40 (2.58-2.40) 19.26-3.20 (4.0-3.2)
No. reflections/No. Rfree 14590/734 (2594/143) 6568/311 (2659/139)
Rwork/Rfree 0.197/0.243 (0.214/0.266) 0.185/0.242 (0.216/0.299)
No. Atoms
Protein 2909 2899
Water 47 17
Metal ions 6 (Mn
2+) 7 (Zn
2+)
Average B-factor 44.2 76.7
R.m.s deviations
Bond lengths (A ˚) 0.01 0.011
Bond angles (u) 1.15 1.37
aHighest resolution shell is shown in parentheses.
doi:10.1371/journal.pone.0020420.t001
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modelling suggests that metal-induced conformational change
could alter the normal association of VPS29 with the VPS35
subunit by steric interference (Fig. 5C). Our previous pull-down
experiments do not support this [27], and neither do ITC
experiments performed in the presence and absence of excess
MnCl2 or EDTA that show no significant change in the affinity or
thermodynamics of VPS35 association (Fig. 5D). Similar
experiments could not be performed using ZnCl2 due to rapid
precipitation of VPS35 in the presence of this salt even at
concentrations of as little as 0.5 mM.
Structural comparison of VPS29 in crystalline and
solution environments
The NMR assignment of VPS29 places us in an ideal position to
assess conformational dynamics of VPS29 in solution, and
potential structural changes in the protein. From a comparison
of three deposited structures of VPS29 (human VPS29, PDB
1W24; human VPS29 in complex with VPS35, PDB 2R17; mouse
VPS29, PDB 1Z2X) distinct structural differences are observed.
Superimposing the apo and VPS35-bound human protein yields a
low r.m.s.d. of 0.54 A ˚ over 178 backbone atom pairs. Subtle
Figure 5. Metals do not affect VPS29 phosphatase activity or interaction with VPS35. (A) SDS-PAGE gel showing purified VPS29 and
trimeric retromer proteins used for phosphatase assays stained with Coomassie Blue. (B) No detectable phosphatase activity was measured for VPS29
alone or in complex with VPS35 and VPS26. Phosphatase assays used the CI-MPR peptide CSSTKLVSFHDD(pS)DEDLLHI. The release of phosphate was
measured using Biomol Green reagent and colorimetric assay at 620 nm. Calf intestinal alkaline phosphatase (CIAP) is shown for comparison. (C)
When VPS29 has bound metal, the conformation of Phe63 is altered such that it may clash with VPS35 and inhibit binding. The diagram shows a close
up of the interaction between VPS29 and VPS35 [24]. The Mn
2+-bound VPS29 structure (green ribbon, and yellow side-chains) is overlayed with
VPS35-bound VPS29 (blue ribbon and cyan side-chain). VPS35 is shown in surface representation. (D) No significant difference is observed in binding
to VPS35 in the presence of EDTA or MnCl2 indicating that metals do not influence complex formation. VPS29 interaction with VPS35 was analysed by
ITC; top panels show raw data and bottom panels show integrated normalised data.
doi:10.1371/journal.pone.0020420.g005
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also missing density for the N terminal loop of helix a3 (residues 93
and 94) in the apo human VPS29 structure [30]. In comparison, a
superposition of mouse VPS29 and either human structure
demonstrates a dramatic difference in the orientation of helix a3
(residues 96–106) of ,83u, which would preclude binding to
VPS35. We have investigated the functional relevance of these
observed structural differences in the context of potential inter-
subunit crystal packing anomalies and/or as possible effects of
dynamics in solution. In this, we determined whether the
interacting helix has significant mobility in the isolated, mono-
meric VPS29 and if not, whether a substantial reorientation is
required in solution to bind VPS35. To this end, we measured
15N
relaxation parameters to survey the dynamics of VPS29 on the ps-
ns timescale, and have also determined the orientation of helix a3
in solution by NMR using primarily Residual Dipolar Couplings
(RDCs) combined with limited NOE data.
Structural dynamics of VPS29 in solution
To investigate the dynamic properties of VPS29 we recorded
15N T1, T2 and a
15N heteronuclear NOE experiment at a single
field strength (600 MHz) (Fig. 6). A ratio of the T1 and T2 values
is in close agreement with that predicted using HYDRONMR
[34], consistent with a monomeric VPS29 in solution (with a
correlation time of 11.1 ns), and agreeing with gel filtration data.
On first inspection, the relaxation data indicates that VPS29 has
no particularly large amplitude mobile segments as would be
indicated by a stretch of low
15N NOE values,0.5 (Fig. 6). Amide
resonances corresponding to the N-terminal non-native residues
derived from the expression vector do show the low, and typically
negative
15N NOEs characteristic of a disordered peptide. Several
residues however, show a significantly reduced
15N NOE value of
,0.5–0.6 (Leu18, Gln65, and Asn140 through to Asn145) and are
found in loop regions. These residues are buried in the interface of
the VPS29-VPS35 complex [24], and their relative fast timescale
mobility in the apo VPS29 protein is consistent with our previous
hypothesis that this region undergoes structural rigidification upon
complex formation [25]. The sidechain of Leu142 is seen to
change conformation significantly between the apo state and in the
complex with VPS35. The conformational change is accompanied
by a ,9A ˚ translation in the sidechain dC methyl positions of
Leu142. Further evidence to suggest this region is mobile in apo
VPS29 is that a comparison of the RDC data (see next section) to
any of the VPS29 structures for this region gave a poor fit, as
expected for a mobile segment.
Backbone torsional angle and secondary structure prediction
using
13CA,
13CB,
13C,
15N and
1HN chemical shifts within
TALOS+ [35] showed that the secondary structural elements of
VPS29, including the a3 helix, are predicted with high confidence
in solution to be the same as in the crystal structure (Fig. 6B).
Furthermore, the
15N NOE data shows that the a3 helix and
preceding loop region appears not to have large amplitude
mobility in solution on the fast (ps-ns) timescale. These finding
prompted us to look more closely at the relative orientations of the
structural elements of VPS29, and consider using RDC measure-
ments to specifically investigate the conformational orientation of
the a3 helix in solution as described in the following section.
Careful inspection reveals a noticeable decrease in the T2 values
for a few, but not all residues in the a3 helix and preceding loop
(residues 90, 96, 98, 103). This observation is suggestive of either
Rex contribution to the
15N T2 for these residues, or that the helix
is possibly pointing along the main axis of the diffusion tensor, and
these residues are tumbling effectively like that of a larger protein.
Given that amide broadening is not observed from residues along
the length of the helix (data not shown), it is more likely to be due
to the indirect effect of e.g. proximal sidechains rather than ms-ms
motion of the helix in general.
A number of residues show decreased T2 values, paralleled by
the observation of significant broadening in the
15N-HSQC
spectra, indicating ms-ms motions (Fig. 6B). These are Asn39,
Val56, His86, Gly94, Asp109, and Tyr129. Asn39 (the central
bridging residue of the metal-binding pocket) is in a loop region
and the observed T2 and broadening is most likely due to general
motion in this loop region. Val56 HN is at the edge of the sheet
and although several backbone long range NOEs are observed
between residues 33/55, 34/57 and 34/56 confirming the parallel
sheet arrangement, the HN is solvent exposed and not directly
part of the sheet hydrogen bond network that would presumably
dampen any motions. Interestingly, Tyr129 and Ile112, which are
Figure 6.
15N NMR relaxation data for VPS29 indicates a
generally rigid structure with no large-scale mobility with well
defined secondary structural elements. (A) Longitudinal T1 and
transverse T2 relaxation times as well as the {
1H}
15N heteronuclear NOEs
are shown as a function of protein sequence. Residues within helix a3
are highlighted in grey. Six N-terminal (non-native) resides are shown
and are labelled as residues 201–206. The protein secondary structure is
indicated at the bottom of the figure. Data was recorded using a
600 MHz spectrometer. (B) The TALOS+ artificial neural network (ANN)-
predicted secondary structural elements of VPS29. Length of bars
corresponds to probability of a residue to be helix (black) or b-strand
(grey).
doi:10.1371/journal.pone.0020420.g006
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for T1 and T2 fitting, lie underneath the a3 helix in the middle of
the sheet. Broadening may be due to motions not in loops but from
residues in the proximal helix a3, the side-chains therein or simply
from nearby residues.
Some amide resonances are broadened beyond detection in the
15N-HSQC experiment which suggests severe ms-ms conforma-
tional exchange for these amide residues (or the possibility that
they resonate directly under the water). These include Trp93 and
Gly94. Interestingly, the parallel lack of density for this region in
the human X-ray VPS29 structure is also indicative of conforma-
tional exchange and flexibility. It has to be noted, that the
observation of line broadening in NMR spectra does not imply
that the populations of the other conformations in exchange are
large, as populations as little as 1% can lead to substantial
broadening [36].
Solution conformation of the a3 helix of VPS29
As described above, previous crystal structures show that VPS29
can adopt two very different conformations, an open form where
the a3 helix is free of intra-molecular contacts forming an
extended structure, and a compact form whereby the a3 helix is
packed closely against the central b-sandwich of VPS29 (Fig. 7A).
The compact form is observed in the crystal structure of apo
human VPS29, and the crystal structure of human VPS29 bound
to VPS35(476–780) where helix a3 also forms extensive contacts
with the VPS35 protein [23,28]. The extended form of VPS29 is
observed in the crystal structure of mouse VPS29, and in this
structure the open a3 helix is stabilised by contacts that create a
non-crystallographic VPS29 dimer within the asymmetric unit
[27]. In the extended conformation observed in mouse VPS29,
helix a3 would preclude complex formation with VPS35. As the
human and mouse proteins are essentially identical in sequence,
the observed conformational differences are either due to crystal
packing or reflect a true dynamic flexibility in a region of VPS29
critical for VPS35 binding (or both).
Over the last decade there has been a growing interest in using
RDC calculations as a powerful additional parameter for the
structure refinement of proteins, DNA and RNA and when high-
resolution structures are available, in the rapid determination and
validation of domain-domain orientations in macromolecular
complexes [37,38]. More recently, their utility has been central
to the determination of protein structure using backbone only data
along with Rosetta modelling methodology [39]. RDC measure-
ments have also been elegantly correlated with dynamics in
conjunction with relaxation measurements [40]. Herein we use
RDC measurements to validate the orientation of the a3 helix in
solution.
RDCs were obtained in a PEG/hexanol alignment media.
These measurements allowed us to derive the alignment tensor by
single value decomposition within PALES by fitting 133 measured
15N RDCs [41] to the X-ray structures of mouse or human VPS29
and to back calculate the RDCs for each residue (Fig. 7B, D, E).
From the PALES calculations, the correlation between the 16
observed and calculated RDCs for the a3 helix region (residues
88–104) are significantly better when fitted to either of the human
VPS29 structures than to the mouse VPS29 protein. The
correlation (R) for the 16 RDCs fitted to the mouse X-ray
structure is very poor (0.17) compared to that when fitted to the X-
ray structure of the human apo (0.85) or human/VPS35 structure
(0.89). For the a3 helix region, the measured RDCs are in
excellent agreement with those calculated from the human
structure (Fig. 7D, E) and slightly less so for the human/VPS35
structure. Inclusion of the RDCs for the 142–146 loop were not
included in the calculation of the orientation of the a3 helix
(although they did not skew the final result) but deviations to the
measured RDC of up to 28 Hz were observed (Fig. 7D). It is clear
from the relaxation data (see previous section) that this region is
mobile in solution and different conformations are observed in the
X-ray structures. We also conclude that the difference between the
X-ray and solution structures is not due to interaction with the
neutral PEG/hexanol medium as there were minimal chemical
shift changes. The reduction in the
15N T2 values for selected
amides along the helix does not contradict the RDC findings
which show the major helix conformation is very close to that of
the human crystal structure and therefore any motion (reflected in
a reduced
15N T2) is minimal or an indirect effect.
Adopting a classical NOE analysis to understand the orientation
of the a3 helix is problematic as the NOE distance restraints are
predominantly short range for this scaffold. In this situation, the
orientation of the helix is derived largely by the calibration of the
NOEs in the loop regions either side of the helix and the
observation of a few long-range restraints if they exist to the helix
itself. Compounding the problems with this style of analysis is that
the amides from the residues in the N-terminal loop of the helix
are significantly broadened (Gly94) or absent (Trp93) in the
15N-
HSQC spectra as described above, reducing the number of
potential NOEs in this connecting region. Nonetheless, NOE
analyses provided useful corroborating evidence for the findings
using RDC correlations. Firstly, evidence that helix a3 is not
mobile in solution comes from strong sequential HN-HN NOEs
and several medium range HN-HN(i, i+2), Ha-HN(i, i+3) and Ha-
HN(i, i+4) NOEs observed along the helix (Fig. 7C), diagnostic of
a regular rather than frayed structure. Furthermore the residues in
the helix are not substantially broadened in the
15N-HSQC
spectrum as might be expected if the helix is undergoing large
amplitude (ms-ms) motions, often observed in enzyme active sites
for example [42]. Finally classical NOE evidence further suggests a
predominance of the close-packed orientation of helix a3i n
solution by the observation of two long range NOEs between
Ala100HN, Gln103HN and the side-chain He protons of Tyr 129.
The distances between these two proton pairs in the open a3
orientation is far too long (18 and 13 A ˚ respectively), but in the
compact conformation are short enough for detection by the NOE
(3.87–4.01 A ˚)( Fig. 7A).
Interaction of VPS29 with regulatory proteins
The final question we have addressed using NMR spectroscopy,
is the potential interaction of VPS29 with associated regulatory
proteins. Apart from VPS35, VPS29 has also been shown to
interact with regulatory proteins; the SNX complex Vps5p/
Vps17p in yeast [27], and the Rab GAP TBC1D5 in human cells
[32]. Contrasting results have been seen for the binding of either
TBC1D5 or the SNX complexes in mammalian cells. TBC1D5
interaction is readily detected in immunoprecipitations of GFP-
tagged VPS29 and in yeast 2-hybrid assays, along with other
effectors such as the WASH1/strumpellin complex [32] (R.
Teasdale, personal communication). The interaction of VPS29
with mammalian SNX proteins is more contentious. To date, we
have been unable to detect interactions of VPS29 or the retromer
complex with mammalian SNX proteins in similar conditions as
those used for TBC1D5 [27,32]. For example, in experiments
shown in Fig. 8A, we over-expressed GFP-VPS29 in HeLa cells in
order to enhance potential complex formation, and performed
immunoprecipitations with either the core retromer subunit
VPS26 or the sorting nexin SNX1. As an initial control we first
showed that VPS26 (and hence VPS29-containing retromer)
readily binds the protein strumpellin as shown previously [32].
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differences in the orientations of the a3 helix. VPS29 adopts an extended a3 orientation in the mouse apo VPS29 crystal structure (PDB 1Z2X; green),
and a compact orientation in the VPS35-bound human VPS29 structure (PDB 2R17; blue). Ala100, Gln103 and Tyr129 are shown for each structure, to
show residues for which long-range NOEs are observed. In the apo mouse VPS29 structure these residues would be too far apart to observe these
NOE contacts. (B) RDC correlation plots indicate the apo mouse VPS29 protein adopts a compact structure in solution, where the a3 helix is similar to
the VPS35-bound conformation, but not the previous mouse VPS29 crystal structure. Shown are 133
1DHN RDCs fitted to the apo human VPS29
structure (PDB 1W24), human VPS29 in complex with VPS35 (PDB 2R17) and the mouse VPS29 structure (PDB 1Z2X). The residues of helix a3 are
highlighted in red (95–107). Residue 99 was not included due to severe overlap in the 2D
15N IPAP spectra. Single value decomposition analysis of the
HN-N RDCs to the apo human, VPS35-bound human or apo mouse X-ray structures yielded the following: The largest component of the alignment
tensor (Szz) were 1.31e
23, 1.35e
23, 1.09e
23 and Rhombicities (Syy2Sxy/Szz) were 0.53, 0.53 and 0.48. (C)2 D
1HN-
1H strips from the 3D
15N NOESY-
HSQC show the NOE connectivities along helix a3 (residues 97–107). Diagonal peaks for each strip are labelled with an asterisk and proximal protons
that give rise to observable NOEs are annotated. Medium range i, i+2
1HN-
1HN NOES are underlined while medium range i, i+3 and i, i+4
1Ha-
1HN
NOES are identified with arrows. Both are diagnostic of a regular alpha helix. Two long range NOEs to the He protons of Tyr129 from the
1HN of
Ala100 and Gln103 are labelled as well as the long-range (cross sheet)
1HN-
1HN NOE between Y129 and F122. (D)
1DHN RDCs observed (black)
compared to those calculated for each residue for mouse VPS29 structure (PDB 1Z2X, green), apo human VPS29 structure (PDB 1W24, red) and
human VPS29 in complex with VPS35 (PDB 2R17, blue). (E) Detail comparing the close fit of the
1DHN RDCs to the a3 orientation in the apo human
VPS29 compared to the poor fit to the mouse a3 orientation.
doi:10.1371/journal.pone.0020420.g007
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is retromer binding when SNX1 is used as bait, indicating a weak
or transient interaction in vivo. The lack of binding is not due to
competition by the antibody itself as experiments with epitope-
tagged proteins have yielded similar negative results [27,32].
Although other groups have detected interactions of retromer
(both VPS35 and VPS29 subunits) with SNX proteins using ultra-
sensitive yeast 2-hybrid assays, or over-expression of all retromer
and SNX subunits together [20,43,44], there have been no reports
of binding between endogenous mammalian proteins.
Overall the data suggests that mammalian SNX proteins either
do not specifically associate with VPS29 or do so with much lower
affinity than TBC1D5. To test this hypothesis we used NMR
chemical shift titration experiments to assess the potential
formation of the ,140 kDa VPS29-SNX1 complex and deter-
mine if the two proteins can associate in vitro (Fig. 8).
Unfortunately, poor solubility of TBC1D5 constructs to date have
precluded similar NMR experiments with this molecule. As shown
in Fig. 8B and 8C, clear chemical shift perturbations for VPS29
are observed on SNX1 addition, indicating specific interaction.
Fortunately for the purpose of detection by NMR, the binding is
indeed weak as judged by the observation of fast exchange and
tracking of resonances in the
15N-HSQC spectra of VPS29
recorded in the presence of increasing concentrations of SNX1.
Specific changes in a number of backbone resonances were
observed prior to complete spectral broadening as the equilibrium
shifts to a larger multimer. It was possible to plot the chemical shift
perturbation for Leu26 on increasing SNX1 concentration to
derive an approximate binding affinity (Kd).150 mM( Fig. 8C).
Mapping of the shifted perturbations revealed that the primary site
of SNX1 association occurs at the same hydrophobic surface
identified in the yeast Vps29p protein as being important for
Vps5p/Vps17p association, and for mammalian VPS29 binding to
TBC1D5 (Fig. 8D) [27,32]. In addition, alteration of this
hydrophobic surface by mutating Leu152 to Glu abolishes the
interaction (Fig. 8E). This mutation also blocks TBC1D5 binding
[32], and is analogous to the L252E mutation in yeast Vps29p that
abolishes association of retromer with Vps5p/Vps17p sorting
nexins [27]. This provides compelling evidence that mammalian
VPS29 can associate with both SNX proteins and TBC1D5 via an
Figure 8. VPS29 binds specifically to SNX1 but with low affinity in vitro. (A) Immunoprecipitations from HeLa cells do not detect association
of retromer with SNX1 even in the presence of increased levels of VPS29 expression. Cells expressing GFP-VPS29 or GFP-VPS29(L152E) mutant were
subjected to immunoprecipitation with either VPS26 or SNX1 antibodies. VPS26 (and thus VPS29-containing retromer) associates readily with the
effector complex containing strumpellin [32], confirming that known binding partners can be detected in the immuno-isolates. However, no SNX1 is
detected, and furthermore, in reverse experiments SNX1 does not precipitate retromer indicating that their association in vivo is relatively weak or
transient. (B) Titration of VPS29 with SNX1 in NMR experiments reveals specific but weak association in vitro. A selected region is shown for the
15N-
HSQC spectra of VPS29 in the presence of increasing concentrations of SNX1. (C) Chemical shift perturbations are shown for VPS29 in the presence of
SNX1. Inset shows a plot of the chemical shift perturbation for Leu26 NH as a function of SNX1 concentration. (D) SNX1 binds to VPS29 via the
conserved hydrophobic surface on the opposite face to the metal-binding pocket and VPS35 binding interface. Residues that show the largest
perturbations on SNX1 binding (.2 standard deviations) are mapped on the VPS29 structure in blue. The structure of VPS29 (surface, and green
ribbons) is shown in complex with VPS35(476–780) (red ribbons) [24]. The side-chains of the VPS29 hydrophobic surface are indicated. (E) Mutation of
the hydrophobic surface of VPS29 (L152E) prevents VPS29-SNX1 association. The [
1H,
15N]-HSQC spectra for VPS29(L152E) in the absence (black) and
presence (red) of SNX1 indicates no significant association is occurring.
doi:10.1371/journal.pone.0020420.g008
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affinity for SNX proteins in vitro.
Discussion
In this work we have used a combination of techniques to
examine the conformational changes in the VPS29 subunit of
retromer between its apo and complexed state, and the
functionality of different molecular interactions including metal
binding and association with sorting nexin proteins.
Metal binding and phosphatase activity of VPS29
With the discovery that VPS29 displays structural homology
with metal-dependent PPP phosphatases, initial expectations were
that retromer may regulate endosomal protein trafficking by
dephosphorylating either cargo receptors, regulatory molecules or
possibly even membrane lipids [27,30]. We have carried out an
analysis of the metal binding characteristics of VPS29 and find
that although the protein is able to bind metals in the expected
coordination geometry both in crystals and in solution, the
association is of low affinity. Although metal binding by VPS29 in
the cell cannot be totally excluded based solely on our in vitro
studies, exhaustive phosphatase assays using either small molecule
substrates [27] or a phosphorylated peptide derived from the
retromer cargo molecule CI-MPR have so far failed to detect any
significant enzymatic activity (this study and [24]). Although
phosphatase activity of VPS29 was detected against the CI-MPR
peptide previously [31], we note that protein samples used were
significantly less pure than those used here and by Hierro et al.
[24]. The activity was not quantified and was presumably quite
low based on the fact that assays required very long incubation
periods for detection of free phosphate. It is likely that this low
level of activity may be due to impurities in the protein samples
used.
In summary the weight of biochemical and structural evidence
strongly suggests that neither VPS29 alone or the VPS29-
containing retromer complex is an active phosphatase in vitro.
Could retromer still be a functional phosphatase in vivo? Although
it appears to be unlikely, the answer to this question still remains to
be settled definitively. What is clear is that for activity to be present
there must be processes occurring in a cellular context that are not
recapitulated in vitro. At least two events would need to occur for
enzymatic function. Firstly, a conformational change in the
VPS29-VPS35 interface must take place to allow substrate access
into the active site. This does not appear to happen in vitro but it is
possible that in the cell, in particular in the context of the multi-
component assembly involving SNX proteins, TBC1D5, lipid
association, Rab7 and other molecules including cargo receptors,
the VPS29-VPS35 interface may be altered. Secondly, previous
analyses indicate that VPS29 lacks important active site residues
found in related enzymes [27]. Therefore, it is probable that
activity will depend on a co-factor protein. This could potentially
involve VPS35, but again from our in vitro studies and other work
[24] VPS35 alone is not sufficient to promote catalysis. It will be
important to assess in a cellular environment whether depletion or
mutagenesis of retromer affects dephosphorylation of potential
target proteins before enzymatic activity of the complex can be
ruled out entirely.
Based on differences observed in crystal structures of metal-
bound and unbound VPS29 our modelling suggests metal binding
might be able to regulate complex formation with the large subunit
VPS35; however, we found no indication that metal binding by
VPS29 affects retromer assembly. It is known that mutations in the
metal-binding pocket cause the protein to be less stable, and to be
produced at lower levels when expressed either in mammalian or
bacterial cells [24,27]. Is this instability a consequence of inhibited
metal binding or simply a result of protein misfolding? Based on
the fact that the wildtype protein can be isolated in high yields
without bound metal when expressed in bacteria, and that NMR
and ITC experiments indicate a low affinity for metal ions, we
suggest that the latter is the more likely scenario. Therefore we
propose VPS29 has a phosphatase-like fold, where residues that
can coordinate metal cations have been conserved not for
enzymatic activity but for purposes of protein stability, in
particular within the context of the assembled retromer complex.
We therefore propose that metal binding by VPS29 may not be
required for its function.
Dynamics of VPS29 structure in solution
NMR relaxation measurements are a unique resource for
assessing protein dynamics on a residue-by-residue basis. More-
over these measurements, reporting ps through to ms motions, are
complementary to the intimate structural details provided by X-
ray structures, as often crystal contacts in the latter may artificially
quench local motions [45]. There is a growing body of evidence to
suggest that target sites of proteins have some degree of flexibility,
which is intimately related to how the protein functions [46]. For
example, in some cases relaxation measurements have uncovered
important entropy switching, driving binding events [47,48,49].
From relaxation measurements on mouse VPS29, we have shown
that, in the main, the protein secondary structure elements are
relatively rigid in solution. Combining our residual dipolar
coupling calculations, we propose that the a3 helix functions as
a rigid body, which is presented to VPS35 in a pre-organized and
correct orientation for assembly with respect to the main VPS29
protein scaffold and the metal binding face. Other interfacial loops
nevertheless show some degree of flexibility, often paralleled with
missing density in X-ray structures. It remains to be seen how the
dynamic landscape of VPS29 changes upon complexation with
VPS35 and its other target proteins.
Scaffolding function of VPS29
We previously reported that a conserved hydrophobic surface
on yeast Vps29p was critical for binding of the core retromer
complex to yeast SNX proteins Vps5p and Vps17p [27], and the
mammalian Rab GAP TBC1D5 [32]. Yeast two-hybrid studies
also suggested that mammalian VPS29 is able to associate weakly
with SNX1 and SNX2, both close homologues of yeast Vps5p,
although it remains possible that this could be due to indirect
association of mammalian VPS29 with endogenous yeast retromer
subunits [20]. In this study we have addressed the question of
whether mammalian VPS29 performs a similar role to yeast
Vps29p, via direct interaction with SNX proteins. Using NMR
spectroscopy to measure the binding of VPS29 to mammalian
SNX1 we found a direct association between the two proteins.
This association occurrs via the conserved hydrophobic surface,
centred on residues Leu2, Leu52, Leu152 and Val174 on the
opposite face to the metal-binding pocket and VPS35-binding
interface. This has clear implications for retromer assembly with
SNX proteins in vivo, whereby the SNX membrane tubulating
scaffold binds not only to VPS29 as shown here but also to VPS35
as identified in yeast two-hybrid assays [50]. As this interface is
also responsible for binding to TBC1D5, it will be important to
determine firstly if mutation of the hydrophobic surface of VPS29
results in functional defects in retromer-mediated protein traffick-
ing as expected, and if so how interaction with SNX proteins and
TBC1D5 at this site are spatiotemporally coordinated in the cell.
In vitro the direct association between VPS29 and SNX1 is of low
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core retromer and SNX interaction will be greatly increased by a
number of factors, including oligomerisation of both complexes,
lipid-protein interactions and coordinated binding of cargo and
other membrane-associated proteins such as Rab7 [5,19,20,51].
The region of both mammalian SNX1 and yeast Vps5p that
associates with the core retromer complex has been narrowed
down to an N-terminal domain predicted to contain little
secondary structure [26,52]. Interestingly, this region of SNX1
and SNX2 has been shown to be subject to phosphorylation,
suggesting a potential role for post-translational modification in
regulation of retromer/SNX interactions [53,54]. We have
previously suggested that retromer may bind to SNX proteins in
a manner somewhat analogous to the interaction of linear nuclear
localisation signals with the helical repeats of the importin proteins
[2]. The exact contributions of the large VPS35 subunit and
VPS29 to binding of SNX-dimers, and how these interactions fit
within the model proposed by Hierro et al. [24] for retromer and
SNX protein assembly onto endosomal membranes to form
transport tubules remains an important question.
In conclusion we have provided evidence that although VPS29
retains metal-binding properties, it is not an active phosphatase
enzyme in vitro and likely does not require metal binding for its
function. NMR studies have allowed us to demonstrate confor-
mational rigidity in the a3 helix of VPS29 that associates with
VPS35, and have identified a conserved hydrophobic surface
required for association of VPS29 with sorting nexins and other
regulatory proteins. More generally we find that NMR spectros-
copy is a fast, accurate and sensitive tool that will be well suited to
future studies of VPS29 structure and binding to ligands such as
TBC1D5, and potentially for screens to identify molecules that
interfere with VPS29 function as investigative tools.
Methods
Crystal structure determination
VPS29 was purified and crystallised as described previously
[27], with the minor alteration that PEG3350 was substituted for
PEG3000 in crystallisation solutions. We previously found that
Mn
2+ was able to bind in the VPS29 putative active site and in this
study we examined the ability of Zn
2+ to bind in a similar fashion
by soaking crystals in cryo solution (20% glycerol in mother liquor)
containing 2 mM ZnSO4 for 15 min prior to flash cooling in the
cryostream at 100 K. Crystals of Mn
2+-bound VPS29 were
prepared essentially as described previously. Briefly, crystals of
apo VPS29 were soaked in cryo solution containing 50 mM
MnSO4 for 30 min before flash cooling. Data was collected on the
high-throughput protein crystallography beamline MX2 of the
Australian Synchrotron. Data was integrated using XDS [55],
scaled with SCALA [56], and model refinement and building was
performed with PHENIX [57] and COOT [58]. For the low-
resolution Zn
2+-bound structure NCS restraints and group B-
factors (one per residue) were applied during refinement. All
structure images were made with CCP4mg [59].
Isothermal titration calorimetry
VPS29 and VPS35 were purified essentially as described
previously [27] except that 10 mM EDTA was included during
lysis and affinity chromatography prior to gel filtration and buffer
exchange into 20 mM HEPES (pH 7.4), 100 mM NaCl (ITC
buffer). Experiments were performed using a Microcal iTC200
instrument at 298 K. For metal titrations metal chloride salts at
2.5 mM were titrated into 40 mM VPS29 in 1363.1 ml aliquots.
For VPS35 titrations, 100 mM VPS29 was titrated into 10 mM
VPS35 in 1363.1 ml aliquots in the presence or absence of
0.5 mM MnCl2, or 2.5 mM EDTA in both protein samples. Data
was processed using ORIGIN to derive thermodynamic param-
eters DH, Ka (1/Kd) and the stoichiometry N. DG and DS were
derived from the relations DG=2RTlnKa and DG=DH2TDS.
Phosphatase assay
Phosphatase activity against a phosphorylated peptide derived
from the CI-MPR (CSSTKLVSFHDD(pS)DEDLLHI) were
performed at room temperature in 20 mM HEPES (pH 7.4),
100 mM NaCl. VPS29 and VPS29-VPS35-VPS26 complexes
were purified as described previously [25,27]. Assays in a total
volume of 50 ml used 23 mg peptide (diluted from a 2 mM stock
solution) and either 0.25 mg calf intestinal alkaline phosphatase
(CIAP) (New England Biolabs), 4 mg VPS29 or 10 mg VPS29-
VPS35-VPS26 complex in the presence of 0.2 mM ZnCl2 or
1 mM MnCl2. Reactions were left for 2 h before addition of
100 ml Biomol Green reagent and incubation for 30 min, prior to
measuring absorbance at 620 nm using a microplate reader.
Released phosphate amounts (nmol.min
21.mg
21) were calibrated
against a phosphate standard curve.
Purification of SNX1 for NMR titrations
The human SNX1 gene was cloned into the pMCSG-GST
vector by ligation-independent cloning for expression as a GST-
fusion protein. Protein was expressed in Rosetta BL21(DE3)/
pLysS E. coli cells and cells were lysed using a cell disruptor. After
affinity purification on glutathione sepharose, GST-SNX1 was
cleaved using Tobacco Etch Virus (TEV) protease overnight, and
the resulting SNX1 protein further purified by gel filtration into
NMR buffer, 10 mM HEPES (pH 7.5), 100 mM NaCl and
10 mM DTT.
NMR spectroscopy
Isotopically labelled protein samples for NMR spectroscopy
were prepared using the method of Marley et al. [60]. Briefly, a 2 l
culture of BL21(DE3)-CodonPlus-RIL Eschericia coli cells express-
ing GST-VPS29 was pelleted, washed and resuspended in 500 ml
M9 minimal media containing
15N-labelled NH4Cl2 or
15N-
labelled NH4Cl2 and
13C-labelled glucose as required. Cells were
induced with 0.8 mM IPTG and grown overnight at 293 K. Cells
were lysed by French Press and protein purified by glutathione-
sepharose affinity chromatography in 10 mM Tris (pH 8.0),
100 mM NaCl, 1 mM DTT, before cleavage with thrombin
overnight at 293 K while bound to the column. Proteins were
further purified by gel filtration chromatography in 10 mM
HEPES (pH 7.5), 100 mM NaCl and 0.2 mM DTT. As the
protein precipitated rapidly in air, 10 mM DTT was added to
15N/
13C labelled sample for backbone assignments and the
protein sealed under nitrogen in the NMR tube. In this manner
VPS29 was stable for several weeks. This protein has an additional
N-terminal GSPEFGTRDR sequence derived from the vector.
All NMR experiments were recorded at 298 K on a Varian
Inova 600 MHz NMR spectrometer equipped with a cryoprobe
and Z axis gradients. Triple resonance assignments were
performed using
15N/
13C labelled protein at a concentration of
0.5 mM in 90%/10% H2O/D2O. Backbone assignments were
obtained by recording the following triple resonance three
dimensional experiments; HNCO, HNCA, HN(CO)CA,
HNCACB, CBCA(CO)NH and H(CBCA(CO)NH that was
optimised for detection of Ha [61]. Assignments were further
confirmed using a 3D
15N edited NOESY experiment recorded
with a mixing time of 120 ms [62]. Titrations were performed by
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soFast
15N HMQC experiment [63].
All spectra were processed using nmrPipe [64] and analysed
with XEASY [65].
1DNH RDCs were measured by using 0.1 mM
15N labelled VPS29 in the presence of an anisotropic media
comprising 5% (wt/vol) C12E6/hexanol [66]. RDCs were
obtained by comparing coupled spectra in the presence of the
orienting media against spectra in the isotropic state by recording
a2 D
15N IPAP-HSQC spectrum [67]. RDCs were measured
using SPARKY [68].
1DNH RDCs were fitted to the X-ray
structure of the mouse (PDB 1Z2X) or the human (PDB 2R17;
PDB 1W24) VPS29 using the ‘‘Best fit’’ flag within PALES [41]
and incorporated into the program as the isotropic (J) – aligned
(J+
1DNH) values. The
1DNH RDCs were removed for couplings
derived from severely overlapping peaks in the 2D IPAP spectra
and mobile residues as inferred from
15N relaxation data. The
error in the RDC was conservatively estimated as +/2 2 Hz,
according to the ratio of the linewidth to the signal to noise.
15N Relaxation data was recorded on a ,0.5 mM
15N/
13C
labelled VPS29 sample.
15N heteronuclear NOE spectra were
recorded using TROSY type selection and with watergate
suppression [69] owing to superior sensitivity compared to the
sensitivity enhanced version [70] on the Varian cryoprobe. Three
seconds of weak presaturation was used to generate the desired
heteronuclear NOE and was applied on or off resonance at the
amide proton frequency. T1 and T2 relaxation data was acquired
as described using gradients for selection and for sensitivity
enhancement [70]. The relaxation delay was sampled at 10, 50,
70, 100, 200, 300, 500 ms and 10, 30, 50, 70, 90, 110 ms for
longitudinal and transverse relaxation measurements respectively.
Peak intensities and relaxation times were measured using
SPARKY and Monte Carlo simulation was used for error analysis
in T1 and T2 times. The heteronuclear NOE was calculated and
errors estimated from the base plane noise as implemented within
the program relax [71].
Immunoprecipitation experiments
VPS26, and SNX1 antibodies were described previously [11],
and strumpellin antibody was from Santa Cruz (USA). HeLa cells
stably transfected with VPS29-GFP or VPS29(L152E)-GFP
constructs [27] were grown to ,90% confluency in a 90 mm
tissue culture dish. After removal of cell culture media, cells were
washed with 5 ml of ice cold phosphate buffered saline (PBS). PBS
was removed and cells were suspended in lysis buffer (20 mM
HEPES-KOH (pH 7.0), 50 mM K-acetate, 2 mM EDTA, 0.1%
triton and 200 mM sorbitol) and transferred to a 1.5 ml
microtube. This is the same buffer used for successful native
immunoprecipitation of yeast retromer complexes and SNX
proteins [52]. The lysate was centrifuged at 10,0006ga t4 uC for
5 mins and the supernatant transferred to a fresh tube containing
50 ml of protein-A sepharose (25% slurry). The lysates were
precleared with protein-A sepharose for 30 mins at 4uC, followed
by centrifugation at 10,0006g for 5 min, and the supernatant
transferred to a fresh tube. Affinity purified polyclonal anti-VPS26
or anti-SNX1 antisera was added to each tube. The lysates were
incubated at 4uC for 90 min on a rotating wheel after which 50 ml
of protein-A sepharose was added and the lysates incubated for a
further 60 min. After 4 washes with lysis buffer, the protein-A
sepharose was dried in a vacuum concentrator, resuspended in
SDS-PAGE buffer, heated to 95uC for 5 min and centrifuged to
pellet the sepharose. Samples were analysed by SDS-PAGE and
western blotting using antibodies against VPS26, SNX1 and
strumpellin. Bound antibodies were detected using iodinated
protein-A.
Accession Numbers
Coordinates and structure factors for Mn
2+ and Zn
2+ bound
VPS29 have been deposited in the RCSB PDB with IDs 3PSN
and 3PSO respectively. Raw diffraction data is available on the
Diffraction Images Repository (DIMER) http://xr-diffraction.
imb.uq.edu.au.
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